Supernus Pharmaceuticals, Inc. (SUPN)
42.38
+0.20
(+0.47%)
USD |
NASDAQ |
Oct 02, 16:00
42.40
+0.02
(+0.05%)
After-Hours: 20:00
Supernus Pharmaceuticals Price : 42.38 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 42.47 | 43.15 | 41.88 | 42.38 | 739805.0 |
| Oct 01, 2026 | 43.21 | 43.68 | 42.15 | 42.18 | 424631.0 |
| Sep 30, 2026 | 44.03 | 44.18 | 43.03 | 43.04 | 685590.0 |
| Sep 29, 2026 | 44.39 | 44.93 | 43.20 | 43.97 | 551595.0 |
| Sep 28, 2026 | 42.59 | 44.61 | 42.38 | 44.60 | 731229.0 |
| Sep 25, 2026 | 43.21 | 43.69 | 42.65 | 42.66 | 607569.0 |
| Sep 24, 2026 | 43.22 | 44.00 | 42.76 | 43.29 | 589012.0 |
| Sep 23, 2026 | 43.66 | 44.46 | 43.14 | 43.39 | 544531.0 |
| Sep 22, 2026 | 43.04 | 44.25 | 42.82 | 43.75 | 667588.0 |
| Sep 21, 2026 | 42.00 | 42.97 | 41.68 | 42.78 | 635722.0 |
| Sep 18, 2026 | 42.89 | 42.89 | 41.60 | 42.00 | 1.183M |
| Sep 17, 2026 | 41.66 | 43.40 | 41.46 | 42.92 | 559775.0 |
| Sep 16, 2026 | 41.31 | 41.84 | 40.75 | 41.38 | 787815.0 |
| Sep 15, 2026 | 41.49 | 41.75 | 40.51 | 41.28 | 669223.0 |
| Sep 14, 2026 | 42.16 | 42.54 | 41.23 | 41.49 | 678060.0 |
| Sep 11, 2026 | 41.81 | 42.44 | 41.62 | 41.64 | 707160.0 |
| Sep 10, 2026 | 41.84 | 42.55 | 41.11 | 41.69 | 726750.0 |
| Sep 09, 2026 | 42.17 | 42.59 | 41.50 | 42.07 | 580434.0 |
| Sep 08, 2026 | 43.56 | 43.56 | 42.32 | 42.43 | 429134.0 |
| Sep 04, 2026 | 43.66 | 44.11 | 43.43 | 43.53 | 444197.0 |
| Sep 03, 2026 | 44.56 | 44.56 | 43.16 | 43.97 | 390321.0 |
| Sep 02, 2026 | 44.42 | 45.04 | 43.67 | 44.03 | 445942.0 |
| Sep 01, 2026 | 44.35 | 44.75 | 43.53 | 43.74 | 757781.0 |
| Aug 31, 2026 | 43.82 | 44.37 | 42.84 | 44.21 | 535722.0 |
| Aug 28, 2026 | 43.95 | 44.34 | 43.12 | 43.73 | 487926.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Indivior Pharmaceuticals, Inc. | 35.71 |
| Prestige Consumer Healthcare, Inc. | 45.26 |
| Pfizer Inc. | 27.80 |
| Amphastar Pharmaceuticals, Inc. | 25.43 |
| Bristol Myers Squibb Co. | 61.15 |
Price Related Metrics
| PS Ratio | 2.930 |
| Price to Book Value | 2.390 |
| Price to Free Cash Flow | 129.49 |
| Earnings Yield | -4.52% |
| Market Cap | 2.465B |